Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome--a preliminary study.

Source:http://linkedlifedata.com/resource/pubmed/id/8856622

Download in:

View as

General Info

PMID
8856622